Who Paid My Doc
Joseph Tucci
Endocrinology, Diabetes & Metabolism Providence, RI Medical Doctor
NPI 1780641084 CMS profile 699268
50 Maude St, Providence, RI 02908
General payments
$30,193
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Joseph Tucci of Providence, RI is reported in the CMS Open Payments database as having received $30,193 across 396 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 87th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $121 | 1 | |
| 2023 | General | $1,215 | 59 | |
| 2022 | General | $2,072 | 87 | |
| 2021 | General | $1,677 | 75 | |
| 2020 | General | $4,827 | 92 | |
| 2019 | General | $20,281 | 82 |
Beside peers
- Joseph Tucci
- Endocrinology, Diabetes & Metabolism median
- Middle half of Endocrinology, Diabetes & Metabolism
- National median
In program year 2025, general payments to Joseph Tucci were reported at $121. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.
Show as a table
| Year | Joseph Tucci | Endocrinology, Diabetes & Metabolism median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $20,281 | $494 | $123–$2,253 | $163 |
| 2020 | $4,827 | $335 | $85–$1,841 | $114 |
| 2021 | $1,677 | $398 | $88–$1,981 | $132 |
| 2022 | $2,072 | $364 | $88–$1,568 | $149 |
| 2023 | $1,215 | $420 | $113–$1,614 | $160 |
| 2024 | $0 | $440 | $121–$1,646 | $164 |
| 2025 | $121 | $507 | $135–$1,838 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 14 drugsPart D claims
373
Drug cost
$73,954
Branded share of claims
38.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | Brand | 21 | $25,963 | |
| Kerendia Finerenone | Brand | 13 | $13,318 | |
| Trulicity Dulaglutide | Brand | 11 | $12,118 | |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | Brand | 21 | $11,992 | |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 26 | $2,875 | |
| Synthroid Levothyroxine Sodium | Brand | 23 | $2,862 | |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | Brand | 28 | $2,013 | |
| Levothyroxine Sodium | Generic | 98 | $1,021 | |
| Rosuvastatin Calcium | Generic | 31 | $855 | |
| Alendronate Sodium | Generic | 22 | $344 |
The 10 drugs with the highest cost, of 14 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Records
396 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in Rhode Island
Robert Dobrzynski
Endocrinology, Diabetes & Metabolism · Providence, RI
Frank D'alessandro
Endocrinology, Diabetes & Metabolism · North Providence, RI
Ricardo Correa Marquez
Endocrinology, Diabetes & Metabolism · East Providence, RI
Robert Smith
Endocrinology, Diabetes & Metabolism · Providence, RI
Sudhir Bansal
Endocrinology, Diabetes & Metabolism · Warwick, RI
Judith Gilmore
Endocrinology, Diabetes & Metabolism · Wakefield, RI
Related records
Endocrinology, Diabetes & Metabolism in Rhode Island
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in Rhode Island
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.